9 citations · 27 across the 5 of their papers we have counts for
6 papers
Influencing factors on false positive rates when classifying tumor cell line response to drug treatment
Priyanka Vasanthakumari, Thomas Brettin, Yitan Zhu +6
Informed selection of drug candidates for laboratory experimentation provides an efficient means of identifying suitable anti-cancer treatments. The advancement of artificial intel…
DeepSpeed4Science Initiative: Enabling Large-Scale Scientific Discovery through Sophisticated AI System Technologies
Shuaiwen Leon Song, Bonnie Kruft, Minjia Zhang +89
In the upcoming decade, deep learning may revolutionize the natural sciences, enhancing our capacity to model and predict natural occurrences. This could herald a new era of scient…
Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology images
Alexander Partin, Thomas Brettin, Yitan Zhu +7
Patient-derived xenografts (PDXs) are an appealing platform for preclinical drug studies because the in vivo environment of PDXs helps preserve tumor heterogeneity and usually bett…
A cross-study analysis of drug response prediction in cancer cell lines
Fangfang Xia, Jonathan Allen, Prasanna Balaprakash +21
To enable personalized cancer treatment, machine learning models have been developed to predict drug response as a function of tumor and drug features. However, most algorithm deve…
Learning Curves for Drug Response Prediction in Cancer Cell Lines
Alexander Partin, Thomas Brettin, Yvonne A. Evrard +9
Motivated by the size of cell line drug sensitivity data, researchers have been developing machine learning (ML) models for predicting drug response to advance cancer treatment. As…
Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response
Yitan Zhu, Thomas Brettin, Yvonne A. Evrard +6
Transfer learning has been shown to be effective in many applications in which training data for the target problem are limited but data for a related (source) problem are abundant…